Borrow Scarcity in SLS
SELLAS Life Sciences Group (SLS) is currently exhibiting high borrow fees, placing it among the most expensive stocks to short on the Interactive Brokers platform. High borrow fees are a primary indicator of limited share availability in the lending market. When borrow costs spike, it often reflects a 'hard-to-borrow' status, which can lead to rapid price swings if short sellers are forced to cover their positions due to rising costs or lack of inventory. Traders should note that while this data is specific to the IBKR ecosystem, it serves as a proxy for broader market sentiment regarding the stock's liquidity and the intensity of the bearish conviction.
Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.